Clinical development of Listeria monocytogenes-based immunotherapies.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Seminars in Oncology

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.seminoncol.2012.02.008PMID 22595054PMCID PMC3574585
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction

  2011cited by this paper
• Dynamic Imaging of the Effector Immune Response to Listeria Infection In Vivo

  2011cited by this paper
• Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIV

  2011cited by this paper
• Distinct responses of splenic dendritic cell subsets to infection with Listeria monocytogenes: maturation phenotype, level of infection, and T cell priming capacity ex vivo.

  2011cited by this paper
• Attenuated Listeria monocytogenes vaccine vectors expressing Influenza A nucleoprotein: preclinical evaluation and oral inoculation of volunteers

  2011cited by this paper
• Interplay between CD8α+ Dendritic Cells and Monocytes in Response to Listeria monocytogenes Infection Attenuates T Cell Responses

  2011cited by this paper
• Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity

  2010cited by this paper
• Single dose of anti–CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance

  2010cited by this paper
• Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly

  2010cited by this paper
• Impact of Preexisting Vector-Specific Immunity on Vaccine Potency: Characterization of Listeria monocytogenes-Specific Humoral and Cellular Immunity in Humans and Modeling Studies Using Recombinant Vaccines in Mice

  2009cited by this paper
• The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

  2009cited by this paper
• Antiangiogenesis immunotherapy induces epitope spreading to Her-2/neu resulting in breast tumor immunoediting.

  2009cited by this paper
• Listeria monocytogenes infection in the face of innate immunity

  2009cited by this paper
• Therapeutic cancer vaccines in cervical cancer: phase I study of Lovaxin-C.

  2009cited by this paper
• The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix.

  2009cited by this paper
• Suppression of Cell-Mediated Immunity following Recognition of Phagosome-Confined Bacteria

  2009cited by this paper
• Dendritic Cell Cross-Priming Is Essential for Immune Responses to Listeria monocytogenes

  2009cited by this paper
• Distinct TLR- and NLR-Mediated Transcriptional Responses to an Intracellular Pathogen

  2008cited by this paper
• Shaping and reshaping CD8+ T-cell memory

  2008cited by this paper
• About human tumor antigens to be used in immunotherapy.

  2008cited by this paper
• Constitutive Activation of the PrfA Regulon Enhances the Potency of Vaccines Based on Live-Attenuated and Killed but Metabolically Active Listeria monocytogenes Strains

  2008cited by this paper
• Novel Vaccination Protocol with Two Live Mucosal Vectors Elicits Strong Cell-Mediated Immunity in the Vagina and Protects against Vaginal Virus Challenge1

  2008cited by this paper
• Promises and challenges for the development of Listeria monocytogenes-based immunotherapies

  2008cited by this paper
• Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria

  2008cited by this paper
• Activation of Immature Hepatic NK Cells As Immunotherapy for Liver Metastatic Disease

  2007cited by this paper
• Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.

  2007cited by this paper
• Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement.

  2007cited by this paper
• Human T cell responses against melanoma.

  2006cited by this paper
• Cytosolic Entry Controls CD8+-T-Cell Potency during Bacterial Infection

  2006cited by this paper
• Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes.

  2006cited by this paper
• How Toll-like receptors signal: what we know and what we don't know.

  2006cited by this paper
• Vaccination with irradiated Listeria induces protective T cell immunity.

  2006cited by this paper
• Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy

  2006cited by this paper
• Listeriolysin O-Deficient Listeria monocytogenes as a Vaccine Delivery Vehicle: Antigen-Specific CD8 T Cell Priming and Protective Immunity1

  2006cited by this paper
• CD8alpha+ dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen.

  2006cited by this paper
• DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication.

  2005cited by this paper
• Conditional Lethality Yields a New Vaccine Strain of Listeria monocytogenes for the Induction of Cell-Mediated Immunity

  2005cited by this paper
• The TLR7 Agonist Imiquimod Enhances the Anti-Melanoma Effects of a Recombinant Listeria monocytogenes Vaccine1

  2005cited by this paper
• Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity

  2005cited by this paper
• Identification of Murine Poxvirus-Specific CD8+ CTL Epitopes with Distinct Functional Profiles1

  2005cited by this paper
• Mesothelin

  2004cited by this paper
• Listeria monocytogenes as a Vaccine Vector: Virulence Attenuation or Existing Antivector Immunity Does Not Diminish Therapeutic Efficacy1

  2004cited by this paper
• Immune responses to Listeria monocytogenes

  2004cited by this paper
• Listeria-based cancer vaccines that segregate immunogenicity from toxicity.

  2004cited by this paper
• Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients

  2004cited by this paper
• Vascular Endothelial Growth Factor in Predicting Outcome in Breast Cancer

  2004cited by this paper
• Invasion of mammalian cells by Listeria monocytogenes: functional mimicry to subvert cellular functions.

  2003cited by this paper
• Irradiation of Tumor Cells Up-Regulates Fas and Enhances CTL Lytic Activity and CTL Adoptive Immunotherapy

  2003cited by this paper
• The Induction of HIV Gag-Specific CD8+ T Cells in the Spleen and Gut-Associated Lymphoid Tissue by Parenteral or Mucosal Immunization with Recombinant Listeria monocytogenes HIV Gag1

  2003cited by this paper
• Construction, Characterization, and Use of Two Listeria monocytogenes Site-Specific Phage Integration Vectors

  2002cited by this paper
• Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.

  2002cited by this paper
• Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines.

  2002cited by this paper
• Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.

  2002cited by this paper
• The cell biology of Listeria monocytogenes infection

  2002cited by this paper
• Innate recognition of bacteria by a macrophage cytosolic surveillance pathway

  2002cited by this paper
• In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.

  2002cited by this paper
• Safety and Shedding of an Attenuated Strain of Listeria monocytogenes with a Deletion of actA/plcB in Adult Volunteers: a Dose Escalation Study of Oral Inoculation

  2002cited by this paper
• Listeria Pathogenesis and Molecular Virulence Determinants

  2001cited by this paper
• Priming of Memory But Not Effector CD8 T Cells by a Killed Bacterial Vaccine

  2001cited by this paper
• Antibodies against Listerial Protein 60 Act as an Opsonin for Phagocytosis of Listeria monocytogenes by Human Dendritic Cells

  2001cited by this paper
• Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-161

  2001cited by this paper
• Irradiation induced expression of CD31, ICAM-1 and VCAM-1 in human microvascular endothelial cells.

  2000cited by this paper
• Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun.

  1999cited by this paper
• Pathogenicity and Immunogenicity of aListeria monocytogenes Strain That Requiresd-Alanine for Growth

  1998cited by this paper
• Listeriosis.

  1997cited by this paper
• Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL).

  1997cited by this paper
• Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy.

  1997cited by this paper
• A review of Listeria monocytogenes and listeriosis.

  1997cited by this paper
• Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA

  1997cited by this paper
• Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL).

  1997cited by this paper
• Health risk assessment of Listeria monocytogenes in Canada.

  1996cited by this paper
• Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity.

  1995cited by this paper
• A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours

  1995cited by this paper
• Tumor antigens recognized by T lymphocytes.

  1994cited by this paper
• Induction of protective CD8+ T lymphocytes by an attenuated Listeria monocytogenes actA mutant.

  1992cited by this paper
• Listeria monocytogenes, a Food-Borne Pathogen

  1991cited by this paper
• Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells.

  1991cited by this paper
• Listeria monocytogenes, a food-borne pathogen

  1991cited by this paper
• Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes

  1989cited by this paper

• Live biotherapeutics in cancer therapy.

  2026cites this paper
• Natural carrier systems in cancer vaccines and immunotherapy

  2025cites this paper
• Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines

  2025cites this paper
• Harnessing and Mimicking Bacterial Features to Combat Cancer: From Living Entities to Artificial Mimicking Systems

  2024cites this paper
• Synthetic biology-inspired cell engineering in diagnosis, treatment and drug development

  2023cites this paper
• Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies.

  2023cites this paper
• Hybrid Bacteria System with Nanomaterials for Tumor Therapy

  2023cites this paper
• Bacteria therapeutics for cancer oncology: a crossroads for new paradigms.

  2022cites this paper
• Recent advances in bacterial therapeutics based on sense and response

  2022cites this paper
• The role and mechanisms of the two-component system EnvZ/OmpR on the intracellular survival of Aeromonas hydrophila.

  2022cites this paper
• Bacterially mediated drug delivery and therapeutics: strategies and advancements.

  2022cites this paper
• Bacterial couriers as cancer vaccines

  2022cites this paper
• Prostaglandin E2 induction by cytosolic Listeria monocytogenes in phagocytes is necessary for optimal T-cell priming

  2021cites this paper
• Bacteria and bacterial derivatives as delivery carriers for immunotherapy.

  2021cites this paper
• Robust and Repeatable Biofabrication of Bacteria‐Mediated Drug Delivery Systems: Effect of Conjugation Chemistry, Assembly Process Parameters, and Nanoparticle Size

  2021cites this paper
• Phagocytes produce prostaglandin E2 in response to cytosolic Listeria monocytogenes

  2021cites this paper
• ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer

  2021cites this paper
• Bacteria-Mediated Synergistic Cancer Therapy: Small Microbiome Has a Big Hope

  2021cites this paper
• Immune Checkpoint Blockade in Gastrointestinal Cancers: The Current Status and Emerging Paradigms

  2020cites this paper
• Enhancing mucosal immunity by transient microbiota depletion

  2020cites this paper
• A listeriolysin O subunit vaccine is protective against Listeria monocytogenes.

  2020cites this paper
• Immunogenic clearance-mediated cancer vaccination

  2020cites this paper
• Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer

  2020cites this paper
• Pegvorhyaluronidase alfa

  2020cites this paper
• Intranasal vaccination with Listeria ivanovii as vector of Mycobacterium tuberculosis antigens promotes specific lung-localized cellular and humoral immune responses

  2020cites this paper
• Coating With Chitooligosaccharides Enhances the Cytokine Induction of Listeria ivanovii-Based Vaccine Strain.

  2019cites this paper
• Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer—A Comprehensive Review

  2019cites this paper
• Adaptation to salt stress and protein patterns of L . monocytogenes

  2018cites this paper
• Listeria monocytogenes in Medical Research

  2018cites this paper
• Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks

  2018cites this paper
• Listeria monocytogenes: The Impact of Cell Death on Infection and Immunity

  2018cites this paper
• Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress

  2018influential citation
• Infection with neuroantigen-encoding Listeria: induction of CD8 T cell responses and suppression of demyelinating disease

  2017cites this paper
• Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma

  2017cites this paper
• New Combination Strategies Using Programmed Cell Death 1/Programmed Cell Death Ligand 1 Checkpoint Inhibitors as a Backbone

  2017cites this paper
• The power of combining adoptive cell therapy (ACT) and pathogen-boosted vaccination to treat solid tumors

  2017cites this paper
• A suicidal strain of Listeria monocytogenes is effective as a DNA vaccine delivery system for oral administration.

  2017cites this paper
• Listeria ivanovii Infection in Mice: Restricted to the Liver and Lung with Limited Replication in the Spleen

  2016cites this paper
• Vector-based genetically modified vaccines: Exploiting Jenner’s legacy

  2016cites this paper
• Inflammasome Signaling and Bacterial Infections

  2016cites this paper
• Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges.

  2016cites this paper
• Vaccinia vaccine-based immunotherapy arrests and reverses established pulmonary fibrosis.

  2016cites this paper
• Listeria monocytogenes and the Inflammasome: From Cytosolic Bacteriolysis to Tumor Immunotherapy.

  2016cites this paper
• Listeria monocytogenes-Induced Cell Death Inhibits the Generation of Cell-Mediated Immunity

  2016cites this paper
• Leading Edge Review The Basis of Oncoimmunology

  2016cites this paper
• Disruptive Innovation by Genetic Modification Technology as a Market Driver to Target Unmet Vaccine Needs: Influenza in the Limelight

  2016cites this paper
• The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells

  2015cites this paper
• Chapter 74 – Listeria monocytogenes

  2015cites this paper
• Immune Therapy in Pancreatic Cancer: Now and the Future?

  2015cites this paper
• Immune checkpoint modulation: rational design of combination strategies.

  2015cites this paper
• Attenuated Listeria monocytogenes Vectors Overcome Suppressive Plasma Factors During HIV Infection to Stimulate Myeloid Dendritic Cells to Promote Adaptive Immunity and Reactivation of Latent Virus

  2015cites this paper
• Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines

  2015cites this paper
• Bacterial Cancer Therapy: How Patients Might Benefit from Salmonella Infections

  2015cites this paper
• Cancer vaccines

  2015cites this paper
• A Listeria monocytogenes-Based Vaccine That Secretes Sand Fly Salivary Protein LJM11 Confers Long-Term Protection against Vector-Transmitted Leishmania major

  2014cites this paper
• Enhanced Virus-Specific CD8+ T Cell Responses by Listeria monocytogenes-Infected Dendritic Cells in the Context of Tim-3 Blockade

  2014cites this paper
• Dendritic Cell-Mediated, DNA-Based Vaccination against Hepatitis C Induces the Multi-Epitope-Specific Response of Humanized, HLA Transgenic Mice

  2014cites this paper
• Listeria monocytogenes

  2014cites this paper
• Microsphere priming facilitates induction of potent therapeutic T‐cell immune responses against autochthonous liver cancers

  2014cites this paper
• SnapShot: cancer vaccines.

  2014cites this paper
• Human dendritic cell subsets in vaccination.

  2013cites this paper
• Dendritic-cell-based therapeutic cancer vaccines.

  2013cites this paper
• Analysis of Innate and Adaptive Immune Responses to Listeria Monocytogenes Infection

  2013cites this paper
• Transcutaneous immunization of healthy volunteers with an attenuated Listeria monocytogenes vaccine strain and cholera toxin adjuvant.

  2013cites this paper
• Killed but metabolically active vaccines.

  2012cites this paper
• Cancer immunotherapy via dendritic cells

  2012cites this paper
• Bacterial Toxins in Oncology: Exploring Their Potential as Cancer Therapeutics

  year unknowncites this paper
• Dendritic Cell-Mediated, DNA-Based Vaccination Against Hepatitis Dendritic Cell-Mediated, DNA-Based Vaccination Against Hepatitis C Induces the Multi-Epitope-Specific Response of Humanized, C Induces the Multi-Epitope-Specific Response of Humanized, HLA Transgenic Mice HLA Transgenic Mice

  year unknowncites this paper